USD 0.0
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 163 Thousand USD | -0.61% |
2022 | 164 Thousand USD | -48.85% |
2021 | 320.61 Thousand USD | -60.1% |
2020 | 803.61 Thousand USD | 0.0% |
2019 | 803.61 Thousand USD | 0.0% |
2018 | 803.61 Thousand USD | 0.0% |
2017 | 803.61 Thousand USD | 11.06% |
2016 | 723.61 Thousand USD | -0.0% |
2015 | 723.61 Thousand USD | 0.0% |
2014 | 723.61 Thousand USD | 0.0% |
2013 | 723.61 Thousand USD | 0.0% |
2012 | 723.61 Thousand USD | -0.34% |
2011 | 726.05 Thousand USD | -3.96% |
2010 | 755.95 Thousand USD | 66.24% |
2009 | 454.73 Thousand USD | 65613.58% |
2008 | 692.00 USD | -98.29% |
2007 | 40.41 Thousand USD | -97.17% |
2006 | 1.42 Million USD | -21.17% |
2005 | 1.81 Million USD | 246.57% |
2004 | 522.67 Thousand USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q3 | 163 Thousand USD | 0.0% |
2024 Q2 | 163 Thousand USD | 0.0% |
2024 Q1 | 163 Thousand USD | 0.0% |
2023 Q1 | 164 Thousand USD | 0.0% |
2023 Q4 | 163 Thousand USD | -0.61% |
2023 Q2 | 164 Thousand USD | 0.0% |
2023 FY | 163 Thousand USD | -0.61% |
2023 Q3 | 164 Thousand USD | 0.0% |
2022 Q1 | 320.61 Thousand USD | 0.0% |
2022 Q2 | 164 Thousand USD | -48.85% |
2022 Q3 | 164 Thousand USD | 0.0% |
2022 FY | 164 Thousand USD | -48.85% |
2022 Q4 | 164 Thousand USD | 0.0% |
2021 Q3 | 320.61 Thousand USD | -60.1% |
2021 Q4 | 320.61 Thousand USD | 0.0% |
2021 FY | 320.61 Thousand USD | -60.1% |
2021 Q1 | 803.61 Thousand USD | 0.0% |
2021 Q2 | 803.61 Thousand USD | 0.0% |
2020 Q4 | 803.61 Thousand USD | 0.0% |
2020 Q1 | 803.61 Thousand USD | 0.0% |
2020 Q2 | 803.61 Thousand USD | 0.0% |
2020 Q3 | 803.61 Thousand USD | 0.0% |
2020 FY | 803.61 Thousand USD | 0.0% |
2019 Q3 | 803.61 Thousand USD | 0.0% |
2019 FY | 803.61 Thousand USD | 0.0% |
2019 Q2 | 803.61 Thousand USD | 0.0% |
2019 Q4 | 803.61 Thousand USD | 0.0% |
2019 Q1 | 803.61 Thousand USD | 0.0% |
2018 Q4 | 803.61 Thousand USD | 0.0% |
2018 FY | 803.61 Thousand USD | 0.0% |
2018 Q3 | 803.61 Thousand USD | 0.0% |
2018 Q2 | 803.61 Thousand USD | 0.0% |
2018 Q1 | 803.61 Thousand USD | 0.0% |
2017 Q3 | 803.61 Thousand USD | 6.63% |
2017 Q1 | 723.61 Thousand USD | 0.0% |
2017 FY | 803.61 Thousand USD | 11.06% |
2017 Q4 | 803.61 Thousand USD | 0.0% |
2017 Q2 | 753.61 Thousand USD | 4.15% |
2016 Q1 | 723.61 Thousand USD | 0.0% |
2016 Q4 | 723.61 Thousand USD | 0.0% |
2016 Q3 | 723.61 Thousand USD | -0.0% |
2016 Q2 | 723.61 Thousand USD | 0.0% |
2016 FY | 723.61 Thousand USD | -0.0% |
2015 Q2 | 723.61 Thousand USD | 0.0% |
2015 Q1 | 723.61 Thousand USD | 0.0% |
2015 Q4 | 723.61 Thousand USD | 0.0% |
2015 FY | 723.61 Thousand USD | 0.0% |
2015 Q3 | 723.61 Thousand USD | 0.0% |
2014 Q1 | 723.61 Thousand USD | 0.0% |
2014 Q3 | 723.61 Thousand USD | 0.0% |
2014 Q4 | 723.61 Thousand USD | 0.0% |
2014 FY | 723.61 Thousand USD | 0.0% |
2014 Q2 | 723.61 Thousand USD | 0.0% |
2013 Q4 | 723.61 Thousand USD | 0.0% |
2013 FY | 723.61 Thousand USD | 0.0% |
2013 Q3 | 723.61 Thousand USD | 0.0% |
2013 Q2 | 723.61 Thousand USD | 0.0% |
2013 Q1 | 723.61 Thousand USD | 0.0% |
2012 Q1 | 722.05 Thousand USD | -0.55% |
2012 Q4 | 723.61 Thousand USD | -0.62% |
2012 FY | 723.61 Thousand USD | -0.34% |
2012 Q3 | 728.11 Thousand USD | 0.0% |
2012 Q2 | 728.11 Thousand USD | 0.84% |
2011 Q3 | 739.57 Thousand USD | 5.58% |
2011 Q4 | 726.05 Thousand USD | -1.83% |
2011 FY | 726.05 Thousand USD | -3.96% |
2011 Q1 | 739.15 Thousand USD | -2.22% |
2011 Q2 | 700.49 Thousand USD | -5.23% |
2010 Q1 | 472.79 Thousand USD | 3.97% |
2010 Q2 | 787.21 Thousand USD | 66.5% |
2010 Q4 | 755.95 Thousand USD | -13.36% |
2010 FY | 755.95 Thousand USD | 66.24% |
2010 Q3 | 872.54 Thousand USD | 10.84% |
2009 Q2 | 320.35 Thousand USD | 26.14% |
2009 Q4 | 454.73 Thousand USD | 24.64% |
2009 FY | 454.73 Thousand USD | 65613.58% |
2009 Q1 | 253.97 Thousand USD | 36602.02% |
2009 Q3 | 364.83 Thousand USD | 13.88% |
2008 Q2 | 19.38 Thousand USD | 0.0% |
2008 FY | 692.00 USD | -98.29% |
2008 Q1 | 19.38 Thousand USD | -52.04% |
2008 Q3 | 649.04 Thousand USD | 3248.52% |
2008 Q4 | 692.00 USD | -99.89% |
2007 Q4 | 40.41 Thousand USD | -59.67% |
2007 Q3 | 100.2 Thousand USD | -32.53% |
2007 Q2 | 148.51 Thousand USD | -90.37% |
2007 Q1 | 1.54 Million USD | 8.05% |
2007 FY | 40.41 Thousand USD | -97.17% |
2006 Q2 | 2.29 Million USD | 10.41% |
2006 Q1 | 2.08 Million USD | 14.99% |
2006 FY | 1.42 Million USD | -21.17% |
2006 Q4 | 1.42 Million USD | -43.72% |
2006 Q3 | 2.53 Million USD | 10.33% |
2005 Q4 | 1.81 Million USD | 47.09% |
2005 Q1 | 592.53 Thousand USD | 13.36% |
2005 Q3 | 1.23 Million USD | 25.41% |
2005 FY | 1.81 Million USD | 246.57% |
2005 Q2 | 981.97 Thousand USD | 65.73% |
2004 Q2 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 FY | 522.67 Thousand USD | 0.0% |
2004 Q4 | 522.67 Thousand USD | 0.0% |
2004 Q1 | - USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
American Medical Technologies Inc. | 479.63 Thousand USD | 66.016% |
Ansell Limited | -54.99 Million USD | 100.296% |
Ansell Limited | -55.1 Million USD | 100.296% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | -36.49 Million USD | 100.447% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | -105.1 Thousand USD | 255.087% |
Psykey, Inc. | 634.59 Thousand USD | 74.314% |
ConvaTec Group Plc | 1.2 Billion USD | 99.986% |
ConvaTec Group Plc | 1.2 Billion USD | 99.986% |
Encision Inc. | 1.29 Million USD | 87.371% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | 2.3 Million USD | 92.94% |
Innovative MedTech Inc. | 1.76 Million USD | 90.763% |
LifePoint, Inc. | -3.26 Million USD | 104.994% |
Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 96.676% |
Paradigm Medical Industries, Inc. | 2.16 Million USD | 92.461% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | -43.3 Thousand USD | 476.409% |
Reflect Scientific, Inc. | -1.03 Million USD | 115.744% |
SmileDirectClub, Inc. | 778.67 Million USD | 99.979% |
Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.039% |
SheerVision, Inc. | 57.34 Thousand USD | -184.225% |
United Health Products, Inc. | 660.56 Thousand USD | 75.324% |
Vasamed, Inc. | 22.12 Thousand USD | -636.823% |
Wearable Health Solutions, Inc. | 2.63 Million USD | 93.805% |
Yubo International Biotech Limited | 772.27 Thousand USD | 78.894% |